Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 93

    1.

    The impact of citrate introduction at UK syringe exchange programmes: a retrospective cohort study in Cheshire and Merseyside, UK.

    Beynon CM, McVeigh J, Chandler M, Wareing M, Bellis MA.

    Harm Reduct J. 2007 Dec 11;4:21.

    PMID:
    18072971
    [PubMed]
    Free PMC Article
    2.

    Examination of the association between syringe exchange program (SEP) dispensation policy and SEP client-level syringe coverage among injection drug users.

    Bluthenthal RN, Ridgeway G, Schell T, Anderson R, Flynn NM, Kral AH.

    Addiction. 2007 Apr;102(4):638-46. Epub 2007 Feb 6.

    PMID:
    17286637
    [PubMed - indexed for MEDLINE]
    3.

    The impact of legalizing syringe exchange programs on arrests among injection drug users in California.

    Martinez AN, Bluthenthal RN, Lorvick J, Anderson R, Flynn N, Kral AH.

    J Urban Health. 2007 May;84(3):423-35.

    PMID:
    17265133
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    4.

    Effects of increasing syringe availability on syringe-exchange use and HIV risk: Connecticut, 1990-2001.

    Heimer R, Clair S, Teng W, Grau LE, Khoshnood K, Singer M.

    J Urban Health. 2002 Dec;79(4):556-70.

    PMID:
    12468675
    [PubMed - indexed for MEDLINE]
    5.

    Final Report on Carcinogens Background Document for Formaldehyde.

    National Toxicology Program.

    Rep Carcinog Backgr Doc. 2010 Jan;(10-5981):i-512.

    PMID:
    20737003
    [PubMed - as supplied by publisher]
    6.

    A longitudinal study of syringe acquisition by Puerto Rican injection drug users in New York and Puerto Rico: implications for syringe exchange and distribution programs.

    Finlinson HA, Oliver-Vélez D, Deren S, Cant JG, Colón HM, Robles RR, Kang SY, Andía JF.

    Subst Use Misuse. 2006;41(9):1313-36.

    PMID:
    16861181
    [PubMed - indexed for MEDLINE]
    7.

    Final Report on Carcinogens Background Document for Styrene.

    National Toxicology Program.

    Rep Carcinog Backgr Doc. 2008 Sep;(8-5978):i-398.

    PMID:
    20737009
    [PubMed - as supplied by publisher]
    8.

    Unsafe injecting practices among attendees of syringe exchange programmes in France.

    Valenciano M, Emmanuelli J, Lert F.

    Addiction. 2001 Apr;96(4):597-606.

    PMID:
    11300963
    [PubMed - indexed for MEDLINE]
    10.

    Sterile syringe access conditions and variations in HIV risk among drug injectors in three cities.

    Bluthenthal RN, Malik MR, Grau LE, Singer M, Marshall P, Heimer R; Diffusion of Benefit through Syringe Exchange Study Team.

    Addiction. 2004 Sep;99(9):1136-46.

    PMID:
    15317634
    [PubMed - indexed for MEDLINE]
    12.

    Unmet need for recommended preventive health services among clients of California syringe exchange programs: implications for quality improvement.

    Heinzerling KG, Kral AH, Flynn NM, Anderson RL, Scott A, Gilbert ML, Asch SM, Bluthenthal RN.

    Drug Alcohol Depend. 2006 Feb 1;81(2):167-78. Epub 2005 Jul 25.

    PMID:
    16043308
    [PubMed - indexed for MEDLINE]
    13.

    Syringe use and reuse: effects of syringe exchange programs in four cities.

    Heimer R, Khoshnood K, Bigg D, Guydish J, Junge B.

    J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18 Suppl 1:S37-44.

    PMID:
    9663622
    [PubMed - indexed for MEDLINE]
    14.

    Injection risk behaviors among clients of syringe exchange programs with different syringe dispensation policies.

    Kral AH, Anderson R, Flynn NM, Bluthenthal RN.

    J Acquir Immune Defic Syndr. 2004 Oct 1;37(2):1307-12.

    PMID:
    15385739
    [PubMed - indexed for MEDLINE]
    15.

    Needle sharing and participation in the Amsterdam Syringe Exchange program among HIV-seronegative injecting drug users.

    Hartgers C, van Ameijden EJ, van den Hoek JA, Coutinho RA.

    Public Health Rep. 1992 Nov-Dec;107(6):675-81.

    PMID:
    1454980
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    16.

    [Risk behaviors for HIV transmission among the recent clients of a syringe-exchange program in Madrid, 1993].

    Bravo Portela MJ, Barrio Anta G, de la Fuente de Hoz L, Colomo Gómez C, Royuela Morales L, Estébanez Estébanez P.

    Gac Sanit. 1996 Nov-Dec;10(57):261-73. Spanish.

    PMID:
    9072510
    [PubMed - indexed for MEDLINE]
    17.

    Reductions in HIV risk behaviour and stable HIV prevalence in syringe-exchange clients and other injectors in England.

    Dolan KA, Donoghoe MC, Stimson GV.

    Drug Alcohol Rev. 1993;12(2):133-42.

    PMID:
    16818322
    [PubMed - in process]
    18.

    Over a decade of syringe exchange: results from 1997 UK survey.

    Parsons J, Hickman M, Turnbull PJ, McSweeney T, Stimson GV, Judd A, Roberts K.

    Addiction. 2002 Jul;97(7):845-50.

    PMID:
    12133123
    [PubMed - indexed for MEDLINE]
    19.

    HIV incidence among injecting drug users in New York City syringe-exchange programmes.

    Des Jarlais DC, Marmor M, Paone D, Titus S, Shi Q, Perlis T, Jose B, Friedman SR.

    Lancet. 1996 Oct 12;348(9033):987-91.

    PMID:
    8855855
    [PubMed - indexed for MEDLINE]
    20.

    Changes in HIV risk behaviour in clients of syringe-exchange schemes in England and Scotland.

    Donoghoe MC, Stimson GV, Dolan K, Alldritt L.

    AIDS. 1989 May;3(5):267-72.

    PMID:
    2504230
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk